VSee Health faces Nasdaq delisting over late filing

Published 30/05/2025, 22:44
VSee Health faces Nasdaq delisting over late filing

VSee Health, Inc. has been notified by Nasdaq of non-compliance due to delayed annual report submission. The healthcare services company, which operates under the ticker VSEE, failed to file its Form 10-Q for the period ending March 31, 2025, on time, triggering a notice from Nasdaq’s Listing Qualifications Department on May 23, 2025. With a market capitalization of $18.55 million and a concerning current ratio of 0.37, InvestingPro data indicates the company’s short-term obligations exceed its liquid assets.

The notice does not immediately affect VSee Health’s Nasdaq listing. The company has been given 60 days to present a plan to regain compliance. If Nasdaq accepts the plan, VSee Health could be granted up to 180 days, until October 13, 2025, to resolve the issue. The company’s stock has already faced significant pressure, declining 92% over the past year, while generating revenue of $8.06 million in the last twelve months.

VSee Health intends to submit a compliance plan within the 60-day timeframe and expects to file the overdue Form 10-Q within this period. However, the company cautions there is no guarantee that it will meet this deadline or that Nasdaq will grant an extension.

This development is considered a "forward-looking statement," as it involves projected actions and events that have not yet occurred. The company’s future actions to address this non-compliance are subject to various risks and uncertainties, and there can be no assurance that VSee Health will regain compliance or maintain its Nasdaq listing.

The information in this article is based on a press release statement from VSee Health, Inc.

In other recent news, VSee Health has announced a series of significant developments. The company is currently addressing a compliance issue with Nasdaq due to delayed financial filings for the periods ending March 31, 2025, and December 31, 2024. VSee Health has until June 24, 2025, to present a plan to rectify this issue, which could potentially extend their deadline to October 13, 2025. Meanwhile, VSee Health has launched Project MAMA in the Philippines, a telehealth initiative aimed at reducing maternal mortality rates in rural areas by providing remote consultations with OB-GYN specialists.

Additionally, VSee Health has unveiled its AI-driven Telenursing Robotics platform, designed to automate routine nursing tasks and reduce labor costs in hospitals. The company has also secured a $6 million government contract to deploy flexible telehealth systems, which is expected to boost their revenue. Partnerships with AbundaBox and Ava Robotics further expand VSee Health’s reach in digital health, with new solutions for health record management and telepresence in intensive care.

The company is also enhancing its telehealth solutions by partnering with LanguageLine Solutions to provide interpreter access across over 240 languages. These developments reflect VSee Health’s strategic moves to expand its footprint in the digital health market, supported by a strong pipeline of contracts and partnerships.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.